Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
collection:"CTG"
topic_facet:"Recruitment Status: Not yet recruiting"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Not+yet+recruiting%22&lookfor=%22Myeloma%22&type=Subject
/vufind/Search/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Not+yet+recruiting%22&lookfor=%22Myeloma%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Not+yet+recruiting%22&lookfor=%22Myeloma%22&type=Subject
PubPharm (2.056)
1
Safety and Efficacy of CS1 CAR-T (WS-CART-CS1) in Subjects With Multiple Myeloma : Phase 1 Dose-Escalation and Dose-Expansion Study of the Safety and Efficacy of CS1 CAR-T (WS-CART-CS1) in Subjects With Multiple Myeloma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
A Study of CLN-619 (Anti-MICA/MICB Antibody) in Patients With Relapsed and Refractory Multiple Myeloma : A Phase 1b, Multicenter, Open-Label, Study to Investigate the Safety and Efficacy of CLN-619 (Anti-MICA/MICB Antibody) in Patients With Relapsed and Refractory Multiple Myeloma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
Study of Iberdomide, Bortezomib, Dexamethasone With Isatuximab Added on Demand for ND-NTE MM Patients : A Single Arm, Response-adapted, Open Label Study of Iberdomide, Weekly Bortezomib and Dexamethasone (IberBd) With Isatuximab Added on Demand for Transplant-ineligible, Newly Diagnosed Multiple Myeloma Patients: the BOREALIS Trial
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
An Clinical Study of NKG2D-CAR-NK Cells for the Treatment of Refractory Recurrent Multiple Myeloma : An Exploratory Clinical Study of the Safety and Efficacy of NKG2D Chimeric Antigen Receptor NK Cell Injections for the Treatment of Efractory Recurrent Multiple Myeloma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
A Collaborative Community Effort Using Belantamab Mafodotin in Relapsed/Refractory Myeloma : A Collaborative Community Effort Using Belantamab Mafodotin in Relapsed/Refractory Myeloma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
Plan Development for Giving Teclistamab in the Outpatient Setting : Outpatient-based Teclistamab Step-up Dosing in Patients With Relapsed/Refractory Multiple Myeloma: Process Development in Academic and Community Centres, and Evaluating Impact on Caregiver Burden
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
IMMUNOPLANT for Newly Diagnosed Multiple Myeloma : Immuno-consolidation for Newly Diagnosed Multiple Myeloma Using Lack of MRD Negativity After Initial cOmbination Therapy to Pursue Deeper Responses With Linvoseltamab ANd Delay Transplant
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma : A Phase I First-in-human, Open-label Trial to Investigate the Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0500, A Humanized GPRC5D-BCMA-CD3 Tri-specific Antibody, in Participants With Relapsed or Refractory Multiple Myeloma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma : A Single-arm, Open-label, Phase 2 Study Evaluating Subcutaneous Administration of Isatuximab, Administered by an On Body Delivery System, in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma (RRMM)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
A Real World Study of Equecabtagene Autoleucel in Subjects With Relapsed and Refractory Multiple Myeloma. : A Real World Study of Equecabtagene Autoleucel in Subjects With Relapsed and Refractory Multiple Myeloma.
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[206]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Filter aufheben
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Recruitment Status: Not yet recruiting
Medienart
2.056
Aufsätze
2.056
E-Artikel
2.056
E-Ressourcen
Zeitschriftentitel
1.920
WHO International Clinical Trials Registry Plat...
136
ClinicalTrials.gov
Thema
2.056
610
Recruitment Status: Not yet recruiting
1.918
Study Type: Interventional
642
Phase: Phase 3
474
Phase: Phase 2
135
Multiple Myeloma
127
Phase: Phase 1
117
Neoplasms, Plasma Cell
116
Study Type: Observational
70
Medical Condition: Multiple Myeloma
54
Medical Condition: multiple myeloma
46
Medical Condition: Multiple myeloma
30
Medical Condition: Relapsed and/or Refractory M...
28
Medical Condition: multiple myeloma MedDRA vers...
26
Medical Condition: Multiple Myeloma MedDRA vers...
26
Medical Condition: Multiple myeloma MedDRA vers...
22
Medical Condition: Treatment of bone metastases...
21
Phase: Phase 4
18
Medical Condition: First-Line Multiple Myeloma
18
Medical Condition: Multiple Myeloma MedDRA vers...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
946
2020-
1.110
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
2.012
Englisch
22
Unbestimmt
12
Spanisch
4
Dänisch
4
Deutsch
2
Tschechisch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...